Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Return on Sales (2022 - 2025)

Historic Return on Sales for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to 8.59%.

  • Lucid Diagnostics' Return on Sales rose 19700.0% to 8.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.01%, marking a year-over-year decrease of 13100.0%. This contributed to the annual value of 10.48% for FY2024, which is 112200.0% up from last year.
  • Lucid Diagnostics' Return on Sales amounted to 8.59% in Q3 2025, which was up 19700.0% from 3.7% recorded in Q2 2025.
  • Over the past 5 years, Lucid Diagnostics' Return on Sales peaked at 3.7% during Q2 2025, and registered a low of 188.8% during Q3 2022.
  • Over the past 4 years, Lucid Diagnostics' median Return on Sales value was 14.71% (recorded in 2023), while the average stood at 43.6%.
  • As far as peak fluctuations go, Lucid Diagnostics' Return on Sales surged by 1706600bps in 2023, and later crashed by -219000bps in 2025.
  • Over the past 4 years, Lucid Diagnostics' Return on Sales (Quarter) stood at 133.29% in 2022, then skyrocketed by 92bps to 10.41% in 2023, then increased by 7bps to 9.64% in 2024, then increased by 11bps to 8.59% in 2025.
  • Its Return on Sales stands at 8.59% for Q3 2025, versus 3.7% for Q2 2025 and 32.5% for Q1 2025.